From: Validation of two generic patient-reported outcome measures in patients with type 2 diabetes
Variable Used to Differentiate Groups | Groups | Anxiety |
Depressed Mood |
Positive Well Being | Self Control | General Health | Vitality | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mean | t Value | Mean | t Value | Mean | t Value | Mean | t Value | Mean | t Value | Mean | t Value | ||
ADS Median Split |
ADS Score ≤ 16 (n = 58) | 79.9 | 5.4*** | 89.7 | 5.9*** | 74.3 | 7.6*** | 88.4 | 6.1*** | 73.1 | 5.5*** | 71.2 | 6.5*** |
ADS Score > 16 (n = 72) | 61.8 | 70.3 | 50.4 | 69.6 | 55.7 | 50.1 | |||||||
DSC-R Median Split |
DSC-R Total Score ≤ 0.7 (n = 61) | 81.0 | 6.3*** | 89.5 | 5.9*** | 72.5 | 6.3*** | 89.0 | 6.8*** | 76.1 | 8.1*** | 73.0 | 8.4*** |
DSC-R Total Score > 0.7 (n = 69) | 60.0 | 69.6 | 50.9 | 68.3 | 52.3 | 47.6 | |||||||
Preference for Weight Change |
Lose weight (n = 113) | 68.5 | -1.9 | 77.9 | -1.4 | 60.2 | -1.2 | 77.1 | -1.3 | 61.2 | -3.1** | 57.9 | -2.1* |
Stay same (n = 16) | 79.5 | 86.3 | 67.5 | 84.2 | 77.9 | 70.0 | |||||||
Experienced Hypoglycemia During the Day | Yes (n = 53) | 65.7 | -2.2* | 75.8 | -1.5 | 57.1 | -2.1* | 74.2 | -2.1* | 58.7 | -2.5* | 56.0 | -2.0* |
No (n = 74) | 73.9 | 82.1 | 65.1 | 82.0 | 67.7 | 63.4 | |||||||
Experienced Hypoglycemia During the Night | Yes (n = 23) | 60.5 | -2.6** | 70.4 | -2.0 | 50.0 | -3.1** | 66.1 | -3.7*** | 55.7 | -2.2* | 53.5 | -1.9 |
No (n = 101) | 73.0 | 82.1 | 64.8 | 81.8 | 65.8 | 62.3 | |||||||
Experienced Hyperglycemia | Yes (n = 64) | 67.3 | -1.5 | 76.3 | -1.6 | 57.5 | -2.0* | 75.2 | -1.9 | 62.4 | -0.7 | 54.8 | -2.9** |
No (n = 63) | 73.1 | 82.3 | 65.2 | 81.7 | 65.0 | 65.2 | |||||||
Type of Treatment |
Injectable (n = 31) | 65.5 | -1.1 | 73.5 | -1.2 | 54.7 | -1.6 | 74.8 | -0.7 | 58.7 | -1.4 | 52.4 | -1.6 |
Oral only (n = 85) | 70.9 | 80.1 | 62.5 | 78.0 | 64.7 | 61.0 |